1Hirata M, Akbar SM, Horiike N, et al. Noninvasive diagnosis of the degree of hepatic fibrosis using ultrasonography in patients with chronic liver disease due to hepatitis C virue. Eur J Clin Invest, 2001, 31:528～535
2Maroni M, Mocci F, Visentin S, et al. Periportal fibrosis and other liver ultrasonography findings in vinyl chloride workers. Occup Environ Med, 2003, 60:60～65
3Mateme R, Annet L, Dechambre S, et al. Dynamic computed tomography with low- and high - molecular - mass contract agents to assess microvascular permeabilty modifications in a model of liver fibrosis.ClinSci, 2002, 103:213～216
4Zachariae H, Heickendorff L, Sogasrd H. The vahue of aminoterminsl propeptide of type Ⅲ procollageninroutine screening for methotrexate- induced liver fibrosis: a 10 - year follow - up. Br J Dermato,2001, 144:100～103
5Serejo F, Costa A, Olivera AG, et al. Alpha- interferon improves liver fibrosis in chronic hepatitis C: clinical significance of the serum Nterminal propetide of procollagen tyep Ⅲ. Dig Dis Sci, 2001, 46:1684 ～ 1689
6Walsh KM, Fletcher A, Macsween RN, et al. Basement membrane peptides as markers of liver disease in chronic hepatitis C. J Hepatol,2000, 32:325～330
9Petel K, Lajoie A, Heaton S, et al. Clinical use of hyaluronic acid as a predictor of fibrosis change in hepatitis C. J Gastroenterol Hepatol,2003, 18:253～257
8[1]Tslsumi M, Urashimas H, Matsuda Y, et al. Changes in type Ⅳ collagen content in livers of patients with alcoholic liver disease.Hepatology, 1993, 17: 820
9[4]Eriksson S, Frasser JR, laurent TC, et al. Endothelial cells are a site of uptake and degradation of hyalaronic acid in the liver. Exp cell Res, 1983,144(2) :223
10[5]Friendman SL. Molecular mechanisms of hepatic fibrosis and principles of therapy. J Gastroenterol, 1997,32:424
